Izitolo zefekthri ze-EUR esitokweni CAS 1451-83-8 2-Bromo-3-Methylpropiophenone 2-Bromo-1- (3-methylphenyl) Propan-1-One/236117-38-7/59774-06-0/1009- 14-9/705-60-2

Inkampani yethu igcizelela ukuphatha, ukwethulwa kwabasebenzi abanekhono, kanye nokwakhiwa kwesakhiwo sabasebenzi, izama kanzima ukuthuthukisa ikhwalithi kanye nokuqaphela umthwalo wemfanelo wabasebenzi.Inkampani yethu ithole ngempumelelo Isitifiketi se-IS9001 kanye Nesitifiketi Se-European CE Sezindawo zasembonini ze-EUR esitokweni CAS 1451-83-8 2-Bromo-3-Methylpropiophenone 2-Bromo-1- (3-methylphenyl) Propan-1-One/236117-38 -7/59774-06-0/1009-14-9/705-60-2, Sikukhuthaza ukuthi ubambe njengoba kade sifuna abangani ngaphakathi kwebhizinisi lethu.Siyaqiniseka ukuthi uzodalula ukwenza inkampani nathi hhayi nje kuphela ethelayo kodwa futhi enenzuzo.Sizilungiselele ukukunikeza lokho okudingayo.
Inkampani yethu igcizelela ukuphatha, ukwethulwa kwabasebenzi abanekhono, kanye nokwakhiwa kwesakhiwo sabasebenzi, izama kanzima ukuthuthukisa ikhwalithi kanye nokuqaphela umthwalo wemfanelo wabasebenzi.Inkampani yethu ithole ngempumelelo Isitifiketi se-IS9001 kanye Nesitifiketi se-European CE seI-China 1451 83 8 kanye ne-CAS 1451 83 8, Namuhla imikhiqizo yethu ithengiswa kuwo wonke amazwe asekhaya nakwamanye amazwe ngenxa yokusekelwa kwamakhasimende avamile namasha.Sihlinzeka ngomkhiqizo wekhwalithi ephezulu kanye nentengo yokuncintisana, wamukela amakhasimende avamile namasha abambisana nathi!

I-1-Bromo-2-methoxy-3-nitro-benzene isetshenziswa njengendawo emaphakathi ye-Eltrombopag .
I-Eltrombopag, eyakhiwe yi-GlaxoSmithKline (GSK) e-UK futhi kamuva yathuthukiswa ngokuhlanganyela ne-Novartis e-Switzerland, ingeyokuqala futhi iwukuphela kwe-molecule encane egunyazwe i-non-peptide TPO receptor agonist emhlabeni.I-Eltrombopag yagunyazwa yi-FDA yase-US ngo-2008 yokwelapha i-idiopathic thrombocytopenic purpura (ITP), nango-2014 ukuze kwelashwe i-aplastic anemia enzima (AA).Futhi isidakamizwa sokuqala esigunyazwe yi-US FDA sokwelapha i-AA eminyakeni engama-30 yakamuva.
Ngo-December 2012, i-US FDA yagunyaza i-Elthrombopag yokwelapha i-thrombocytopenia ezigulini ezine-hepatitis C (CHC) engapheli, ukuze iziguli ze-hepatitis C ezinokubikezelwa okungekuhle ngenxa yokubala kweplatelet ephansi zikwazi ukuqala futhi zilondoloze ukwelashwa okujwayelekile okusekelwe kwe-interferon kwezifo zesibindi.NgoFebhuwari3, 2014, i-GlaxoSmithKline yamemezela ukuthi i-FDA inikeze ukuphumelela komuthi wokwelapha i-Eltrombopag wokwelapha i-hemopenia ezigulini ezine-chemicalbook aplastic anemia (SAA) enzima kakhulu engazange iphendule ngokugcwele ku-immunotherapy.Ngomhla zingama-24 ku-Agasti, i-2015, i-US FDA igunyaze i-Eltrombopag yokwelashwa kwe-thrombocytopenia kubantu abadala kanye nezingane ezineminyaka engu-1 nangaphezulu ezine-immune immune thrombocytopenia (ITP) ezingenampendulo eyanele ku-corticosteroids, i-immunoglobulins noma i-splenectomy.NgoJanuwari4, 2018, i-Eltrombopag yagunyazwa ukuthi ifakwe ohlwini e-China ukuze zelashwe i-immune immune thrombocytopenia (ITP).

Inkampani yethu igcizelela ukuphatha, ukwethulwa kwabasebenzi abanekhono, kanye nokwakhiwa kwesakhiwo sabasebenzi, izama kanzima ukuthuthukisa ikhwalithi kanye nokuqaphela umthwalo wemfanelo wabasebenzi.Inkampani yethu ithole ngempumelelo Isitifiketi se-IS9001 kanye Nesitifiketi Se-European CE Sezindawo zasembonini ze-EUR esitokweni CAS 1451-83-8 2-Bromo-3-Methylpropiophenone 2-Bromo-1- (3-methylphenyl) Propan-1-One/236117-38 -7/59774-06-0/1009-14-9/705-60-2, Sikukhuthaza ukuthi ubambe njengoba kade sifuna abangani ngaphakathi kwebhizinisi lethu.Siyaqiniseka ukuthi uzodalula ukwenza inkampani nathi hhayi nje kuphela ethelayo kodwa futhi enenzuzo.Sizilungiselele ukukunikeza lokho okudingayo.
Izitolo zemboni zeI-China 1451 83 8 kanye ne-CAS 1451 83 8, Namuhla imikhiqizo yethu ithengiswa kuwo wonke amazwe asekhaya nakwamanye amazwe ngenxa yokusekelwa kwamakhasimende avamile namasha.Sihlinzeka ngomkhiqizo wekhwalithi ephezulu kanye nentengo yokuncintisana, wamukela amakhasimende avamile namasha abambisana nathi!